Product Description: Anti-IGFBP2 Antibody (M14) is an human anti-IGFBP2 monoclonal inhibitory antibody, which binds IGFBP2 with high affinity and blocks its binding with IGF1. Anti-IGFBP2 Antibody (M14) inhibits human endothelial cell recruitment, thus blocks the tumor progression of human metastatic cancer[1].
Applications: Cancer-Kinase/protease
Formula: N/A
References: [1]TAVAZOIE S, et al., Treatment of angiogenesis disorders. WO2012109567A2.
Molecular Weight: (146.7 kDa)
Compound Purity: 99.0
Research Area: Cancer
Target: IGF-1R